Shingles (Herpes Zoster) Vaccination
CDC recommends Shingrix for adults 50 years and older. Even people who have had shingles or previously got Zostavax can be vaccinated with Shingrix to prevent shingles and the complications caused by the disease.
Shingles is a painful rash that usually develops on one side of the body, often the face or torso. The rash consists of blisters that typically scab over in 7 to 10 days and clears up within 2 to 4 weeks. Some people describe the pain as an intense burning sensation. For some people, the pain can last for months or even years after the rash goes away. This long-lasting pain is called postherpetic neuralgia (PHN), and it is the most common complication of shingles. Your risk of getting shingles and PHN increases as you get older.
A new shingles vaccine called Shingrix (recombinant zoster vaccine) was licensed by the U.S. Food and Drug Administration (FDA) in 2017. CDC recommends that healthy adults 50 years and older get two doses of Shingrix, 2 to 6 months apart. Shingrix provides strong protection against shingles and PHN. Shingrix is the preferred vaccine, over Zostavax® (zoster vaccine live), a shingles vaccine in use since 2006.
What Everyone Should Know About Shingles Vaccines
You should make every effort to get the second dose of Shingrix between 2 and 6 months after you got the first dose. If your doctor or pharmacist is out of Shingrix, you can use the Vaccine Finder to help find other providers who have Shingrix. You can also contact pharmacies in your area and request to be put on a waiting list for Shingrix if they do not have the vaccine in stock. If it’s been more than 6 months since you got the first dose, you should get the second dose as soon as possible; you don’t need to restart the vaccine series.
Your risk of shingles and postherpetic neuralgia (PHN) increases as you get older. CDC recommends that healthy adults 50 years and older get two doses of the shingles vaccine called Shingrix (recombinant zoster vaccine), separated by 2 to 6 months, to prevent shingles and PHN. Shingrix is the preferred vaccine, over Zostavax® (zoster vaccine live), a shingles vaccine in use since 2006. Zostavax may still be used to prevent shingles in healthy adults 60 years and older. For example, you could use Zostavax if a person is allergic to Shingrix, prefers Zostavax, or requests immediate vaccination and Shingrix is unavailable.
https://www.cdc.gov/vaccines/vpd/shingles/index.html